Intelligent Investment
Shanghai Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read
Overview
- Shanghai stands as one of China’s two comprehensive life sciences clusters, alongside Beijing, offering a spectrum of research and development (R&D), manufacturing, medical technology and front office or headquarters corporate space.
- Shanghai’s life sciences ecosystem is anchored by one of the largest life sciences business parks in Asia, Zhagnjiang Science City.
- Lingang Life Sciences Park is a newly developed area experiencing significant construction, particularly for domestic biopharma companies. Ultimately, roughly 20 million sq. ft. is planned for this area.
Submarkets
Industry Presence
- Total leasable space in main clusters of Beijing
Figure 1: Leasable Area of Science Park Life Sciences Space
* Rough approximations of leasable areas; Lingang mostly planned.
Life Sciences Venture Capital Investment Trends
Figure 2: Life Sciences Venture Capital Funding
Life Sciences Market Stats
Figure 3: Asking Rents for Science ParkLife Sciences Space
- Amgen
- AstraZeneca
- Bayer
- Eli Lilly
- GSK
- Johnson & Johnson
- Moderna
- Novartis
- Pfizer
- Roche
- Sanofi
- Simcere Pharmaceutical
- Fudan University
- Shanghai Jiao Tong University
- Shanghai University of Traditional Chinese Medicine
- Tongji University
Global Life Science Markets
-
Beijing is one of China’s two comprehensive life sciences clusters, alongside Shanghai, that offer a spectrum of research and development (R&D), manufacturing, medical technology and front office or headquarters space.
-
Singapore is one of the few markets in Asia-Pacific with a full end-to-end value chain—manufacturing, research and development (R&D), sales and logistics.
-
Greater Tokyo offers Japan’s most comprehensive life sciences industry presence from research and development (R&D) to front office and headquarters locations.